Bridges Investment Management Inc. Has $332,000 Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

Bridges Investment Management Inc. lifted its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 3.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,121 shares of the company’s stock after purchasing an additional 517 shares during the period. Bridges Investment Management Inc.’s holdings in ARK Genomic Revolution ETF were worth $332,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. First Horizon Advisors Inc. raised its position in ARK Genomic Revolution ETF by 9.4% during the second quarter. First Horizon Advisors Inc. now owns 4,650 shares of the company’s stock valued at $109,000 after buying an additional 398 shares during the period. Hilltop Holdings Inc. raised its position in ARK Genomic Revolution ETF by 6.0% during the fourth quarter. Hilltop Holdings Inc. now owns 7,652 shares of the company’s stock valued at $251,000 after buying an additional 433 shares during the period. Prospect Financial Services LLC raised its position in ARK Genomic Revolution ETF by 3.7% during the second quarter. Prospect Financial Services LLC now owns 14,093 shares of the company’s stock valued at $331,000 after buying an additional 500 shares during the period. Brown Miller Wealth Management LLC raised its position in ARK Genomic Revolution ETF by 4.4% during the first quarter. Brown Miller Wealth Management LLC now owns 16,823 shares of the company’s stock valued at $483,000 after buying an additional 714 shares during the period. Finally, Principal Securities Inc. acquired a new position in ARK Genomic Revolution ETF during the fourth quarter valued at $32,000.

ARK Genomic Revolution ETF Trading Down 1.9 %

BATS:ARKG opened at $26.25 on Monday. The company’s fifty day simple moving average is $25.81 and its two-hundred day simple moving average is $25.76.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.